英赛德 INSM
$114.41 +$5.65 (+5.19%)
休市 · Nov 6, 9:50 pm ET · 最新盘后价 $114.78 +0.33%
开盘$108.57
昨收$108.76
当日区间$107.29 – $114.65
成交量3.38M
市值$25.10B
市盈率（TTM）–
股息率–
INSM 相关新闻
匹配 Insmed 或代码 INSM 的头条新闻，按最新排序。
- Barclays Maintains Insmed(INSM.US) With Buy Rating, Cuts Target Price to $207 负面
- J.P. Morgan Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $175
- Goldman Sachs Maintains Insmed(INSM.US) With Buy Rating, Cuts Target Price to $188 负面
- Mizuho Securities Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $195
- BofA Securities Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $214
- Roth MKM Maintains Insmed(INSM.US) With Buy Rating, Cuts Target Price to $198 负面
- Morgan Stanley Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $218
- A Quick Look at Today's Ratings for Insmed(INSM.US), With a Forecast Between $170 to $237
- A Quick Look at Today's Ratings for Insmed(INSM.US), With a Forecast Between $169 to $243
- BofA Securities Maintains Insmed(INSM.US) With Buy Rating, Cuts Target Price to $209 负面
- RBC Capital Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $195
- Mizuho Securities Maintains Insmed(INSM.US) With Buy Rating, Raises Target Price to $195 正面
- BMO Capital Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $192
- Truist Financial Maintains Insmed(INSM.US) With Buy Rating, Announces Target Price $195
- J.P. Morgan Maintains Insmed(INSM.US) With Buy Rating, Cuts Target Price to $175 负面
暂无评论——快来第一个聊聊 INSM。
登录后参与讨论。